ArticleFrontiers in immunology2026

Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group.

Piero Ruscitti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.